A new chapter in precision medicine: Circulating tumor cells in breast cancer prognosis and treatment
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-09 · 1881 (4) · 189656
DOI: 10.1016/j.bbcan.2026.189656 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-09. Verfasst von Chentao Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejia…. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Breast Neoplasms, Precision Medicine, Biomarkers, Tumor. Die Arbeit nennt 150 Literaturangaben. Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Breast cancer (BC) persists as a leading cause of cancer-related mortality among women globally. While the characterization of molecular subtypes has improved our understanding and precision treatment of the disease, the detection and analysis of circulating tumor cells (CTCs) offer a complementary, dynamic perspective. Shed from primary tumors or metastatic sites, CTCs function as pro-metastatic precursors, providing critical insights into tumor progression, metastatic potential, and therapeutic response. We synthesize findings from key clinical trials that underscore the utility of CTCs in early diagnosis, prognostic assessment, and real-time treatment monitoring. Furthermore, we explore the potential of CTCs in uncovering novel biomarkers of therapy resistance and their emerging role in drug development. Ultimately, the integration of CTC-based liquid biopsies into clinical practice promises to open new avenues for precision medicine in BC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
- Department of Medical Oncology, Sir Run Run Shaw hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
- Department of Medical Oncology, Sir Run Run Shaw hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. Electronic address: wangx118@zju.edu.cn.
- Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. Electronic address: jinhc@zju.edu.cn.
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Li, C., Chen, M., Wang, Z., Wang, X., & Jin, H. (2026). A new chapter in precision medicine: Circulating tumor cells in breast cancer prognosis and treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(4), 189656. https://doi.org/10.1016/j.bbcan.2026.189656
Vancouver
Li C, Chen M, Wang Z, Wang X, Jin H. A new chapter in precision medicine: Circulating tumor cells in breast cancer prognosis and treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(4):189656. doi:10.1016/j.bbcan.2026.189656
BibTeX
@article{Li2026,
author = {Li, Chentao and Chen, Miaoqi and Wang, Zhuo and Wang, Xian and Jin, Hongchuan},
title = {A new chapter in precision medicine: Circulating tumor cells in breast cancer prognosis and treatment},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
volume = {1881},
number = {4},
pages = {189656},
doi = {10.1016/j.bbcan.2026.189656}
}
EUVIMED